Nested Case–Control Study of Cervical Mucosal Lesions, Ectopy, and Incident HIV Infection Among Women in Cape Town, South Africa

Objective: The objective of this study was to test whether cervical mucosal lesions and ectopy increase women's susceptibility to HIV infection. Study Design: HIV-seronegative women ages 35 to 65 years (n = 5773) enrolled into a cervical cancer screening trial were followed for up to 36 months. All HIV seroconverters (n = 86) in the cohort were compared with randomly selected controls (n = 324) who did not seroconvert. Magnified photographs of the cervix taken during speculum examination at enrollment were evaluated for cervical mucosal lesions and ectopy using standard criteria. Results: The presence of mucosal lesions (observed among 19% of controls) was associated with increased risk of HIV seroconversion (adjusted odds ratio [AOR] = 1.93; 95% confidence interval [CI] = 1.07–3.48). Ectopy extending over >20% of the cervix was also associated with HIV seroconversion (AOR = 2.18; 95% CI = 1.01–4.69). Conclusions: Visible lesions of cervical mucosa and cervical ectopy may be markers of increased susceptibility to HIV infection among women. Protection of the mucosa of the cervix may provide an important approach for new HIV prevention technologies.

[1]  J. Baeten,et al.  Re: distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: a prospective study of South African women. , 2006, American journal of epidemiology.

[2]  L. Myer,et al.  Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms. , 2005, The Lancet. Infectious diseases.

[3]  Thomas C Wright,et al.  Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. , 2005, JAMA.

[4]  Michelle de Souza,et al.  Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. , 2005, The Journal of infectious diseases.

[5]  N. Sewankambo,et al.  Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study , 2005, The Lancet.

[6]  T. Quinn,et al.  Developments in STD/HIV interactions: the intertwining epidemics of HIV and HSV-2. , 2005, Infectious disease clinics of North America.

[7]  A. Minnis,et al.  Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions , 2005, Sexually Transmitted Infections.

[8]  R. Doms,et al.  HIV Transmission , 2004, The Journal of experimental medicine.

[9]  Debra T. Silverman,et al.  Selection of controls in case-control studies. II. Types of controls. , 1992, American journal of epidemiology.

[10]  H. Rees,et al.  Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial , 2002, The Lancet.

[11]  N. Padian,et al.  Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices , 2001, AIDS.

[12]  S. Vermund,et al.  Cervical ectopy in adolescent girls with and without human immunodeficiency virus infection. , 2001, The Journal of infectious diseases.

[13]  C. Mauck,et al.  The use of colposcopy in assessing vaginal irritation in research. , 2000, AIDS.

[14]  P. V. Rao,et al.  Applied Survival Analysis: Regression Modeling of Time to Event Data , 2000 .

[15]  J. H. van de Wijgert,et al.  Effect of Intravaginal Practices on the Vaginal and Cervical Mucosa of Zimbabwean Women , 2000, Journal of acquired immune deficiency syndromes.

[16]  L. Peralta,et al.  Histologic Development of Cervical Ectopy: Relationship to Reproductive Hormones , 2000, Sexually transmitted diseases.

[17]  D. Richman,et al.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. , 1999, Science.

[18]  S. A. Abdool Karim,et al.  Phase 1 trial of nonoxynol-9 film among sex workers in South Africa. , 1999, AIDS.

[19]  T. Wright,et al.  Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera. , 1999, Contraception.

[20]  W. Levine,et al.  Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. , 1998, The Journal of infectious diseases.

[21]  K. Holmes,et al.  Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking, and douching. , 1995, American journal of obstetrics and gynecology.

[22]  P. Feldblum,et al.  Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers. , 1995, Genitourinary medicine.

[23]  D. Hunter,et al.  Contraceptive use and the risk of HIV infection in Nairobi, Kenya , 1995, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[24]  Adriano Lazzarin,et al.  The Efficiency of Male‐to Female and Female‐to‐Male Sexual Transmission of the Human Immunodeficiency Virus: A Study of 730 Stable Couples , 1994, Epidemiology.

[25]  M. Cheang,et al.  Human immunodeficiency virus type 1 seroconversion in women with genital ulcers. , 1994, The Journal of infectious diseases.

[26]  Judith E. Brown,et al.  The Use and Physical Effects of Intravaginal Substances in Zairian Women , 1993, Sexually transmitted diseases.

[27]  J K McLaughlin,et al.  Selection of controls in case-control studies. III. Design options. , 1992, American journal of epidemiology.

[28]  K. Holmes,et al.  Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: results of a study of couples in Nairobi, Kenya. , 1991, The Journal of infectious diseases.

[29]  S Wacholder,et al.  Selecting an efficient design for assessing exposure-disease relationships in an assembled cohort. , 1991, Biometrics.

[30]  K. Holmes,et al.  Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations , 1983 .

[31]  J W DUGGAN,et al.  Herpes simplex virus. , 1961, Transactions of the Canadian Ophthalmological Society.